JMB-HEADER RAS-JOURNALS EIMB Pleiades Publishing

RUS

             

ENG
Vol 58(2024) N 2 p. 192-204; DOI 10.1134/S0026893324020134 Full Text

A.M. Schwartz1,2, K.A. Tatosyan1,3, D.V. Stasenko1, D.A. Kramerov1*

Regulation of Transcription by RNA Polymerase III Promotors in the Norm and Pathology

1Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, 119991 Russia
2Department of Human Biology, Faculty of Natural Sciences, University of Haifa, Haifa, 3498838 Israel
3Department of Biochemistry, Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, 31096 Israel


*kramerov@eimb.ru
Received - 2023-10-03; Revised - 2023-10-03; Accepted - 2023-10-23

RNA polymerase III synthesizes a wide range of noncoding RNAs shorter than 400 nucleotides in length. These RNAs are involved in protein synthesis (tRNA, 5S rRNA, and 7SL RNA), maturation, and splicing of different types of RNA (RPR, MRP RNA, and U6 snRNA), regulation of transcription (7SK RNA), replication (Y RNA), and intracellular transport (vault RNA). BC200 and BC1 RNA genes are transcribed by RNA polymerase III in neurons only where these RNAs regulate protein synthesis. Mutations in the regulatory elements of the genes transcribed by RNA polymerase III as well as in transcription factors of this RNA polymerase are associated with the development of a number of diseases, primarily oncological and neurological. In this regard, the mechanisms of regulation of the expression of the genes containing various RNA polymerase III promoters were actively studied. This review describes the structural and functional classification of polymerase III promoters, as well as the factors involved in the regulation of promoters of different types. A number of examples demonstrate the role of the described factors in the pathogenesis of human diseases.

RNA polymerase III, genes, promotors, transcription factors, noncoding RNA, mammals, human pathologies



JMB-FOOTER RAS-JOURNALS